BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, has completed construction of a new state-of-the-art manufacturing facility. The new facility is located at the company’s headquarters in Ness Ziona, Israel and will support clinical manufacturing of BiomX’s candidate phage products and in the future could be expanded to support commercial manufacturing needs.    “In this new age of live biotherapeutics, which include phage as well as human...